Suppr超能文献

类风湿因子活性、类风湿关节炎起病年龄及X线进展——一项回顾性研究

[Rheumatoid factor activity, age at manifestation and roentgenologic progression of rheumatoid arthritis--a retrospective study].

作者信息

Hein G, Eidner G, Eidner T, Marzoll I, Klinner M

机构信息

Funktionsbereich Rheumatologie/Osteologie, Klinik für Innere Medizin IV, Friedrich-Schiller-Universität Jena.

出版信息

Z Rheumatol. 1993 Nov-Dec;52(6):403-8.

PMID:8147135
Abstract

The outcome of RF-activity (measured by hemagglutination in the modification of Podliachouk-Harboe) was investigated in 95 patients with RA. In 52 of these patients the radiological progression (modification of Larsen index for hands and feet) in correlation to the outcome of RF was assessed. The results can be summarized in the following way: 1. Elderly RA patients show a significant elevation of RF titer. 2. There is a statistically insignificant correlation between age of RA manifestation and RF level. 3. The investigation of individual RF outcome shows that 54% of the patients have a relatively constant RF level, 15% tend to a decrease of the level of RF activity. Increased RF activity could only be demonstrated in 31% of the patients in the follow-up. 4. We more often observed a decrease of RF activity in RA cases with a disease manifestation < 30 y. We found no significant decrease in the follow-up in cases with manifestation > 60 y. 5. RA patients with a high level of RF activity (HAR > 1:512) have a significantly higher radiological progression index than cases with a low RF activity (HAR < 1:512).

摘要

在95例类风湿关节炎(RA)患者中研究了类风湿因子(RF)活性结果(通过Podliachouk-Harboe改良法中的血凝反应测量)。在其中52例患者中,评估了与RF结果相关的放射学进展(手和脚的Larsen指数改良)。结果可总结如下:1. 老年RA患者的RF滴度显著升高。2. RA发病年龄与RF水平之间存在统计学上无显著意义的相关性。3. 对个体RF结果的研究表明,54%的患者RF水平相对恒定,15%的患者RF活性水平呈下降趋势。随访中仅31%的患者RF活性增加。4. 在发病<30岁的RA病例中,我们更常观察到RF活性下降。在发病>60岁的病例中,随访时未发现显著下降。5. RF活性水平高(血凝反应>1:512)的RA患者的放射学进展指数显著高于RF活性水平低(血凝反应<1:512)的病例。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验